We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Prediction of response to dupilumab treatment.
- Authors
Hijnen, DirkJan; Olydam, Jill
- Abstract
Moving toward endotypes in atopic dermatitis: identification of patient clusters based on serum biomarker analysis. Identifying biomarker-based endotypes that predict treatment response in a heterogeneous, multifactorial disease is evidently more complicated than seeking a biomarker based on the presence of a single gene mutation, as is often the case with, for example, targeted cancer treatments. In this issue of the I BJD i , Wu I et al i . present their search for predictive serum biomarkers in patients with atopic dermatitis (AD) treated with dupilumab.[1] Treatment options for moderate-to-severe AD have evolved since registration of the first biologic, dupilumab, in 2017.
- Subjects
DUPILUMAB; ATOPIC dermatitis; CHOICE (Psychology); FORECASTING; K-means clustering
- Publication
British Journal of Dermatology, 2023, Vol 188, Issue 6, pe41
- ISSN
0007-0963
- Publication type
Article
- DOI
10.1093/bjd/ljad067